Unicycive Therapeutics, Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before October 14, 2025 to Discuss Your Rights – UNCY

Core Points - The Gross Law Firm has issued a notice to shareholders of Unicycive Therapeutics, Inc. regarding a class action lawsuit [1] - Shareholders who purchased shares during the class period from March 29, 2024, to June 27, 2025, are encouraged to contact the firm for possible lead plaintiff appointment [3][4] - Allegations include that Unicycive overstated its readiness to meet FDA manufacturing compliance requirements and the regulatory prospects of its new drug application [3] Class Action Details - The class period for the lawsuit is specified as March 29, 2024, to June 27, 2025 [3] - The deadline for shareholders to register for the class action is October 14, 2025 [4] - Shareholders will be enrolled in a portfolio monitoring software for status updates throughout the case lifecycle [4] Law Firm Information - The Gross Law Firm is a nationally recognized class action law firm focused on protecting investors' rights against deceit and fraud [5] - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [5]